Skip to main content

Bausch Health Companies Inc.'s Form 4 filing

Bausch & Lomb Corp (BLCO) · filed May 12, 2022

Accession no.
0000899243-22-017761
Filed
May 12, 2022
Trade date
May 10, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $597.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bausch Health Companies Inc.CIK 000088559010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 10, 2022Common Shares, No Par ValueSSaleDisposed−35,000,000$17.06−$597,100,000315,000,000Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)